Ryan Allway May 14th, 2021 Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – May 14, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan“), is pleased to announce today that a recent study conducted in mice based on Innocan’s licensed CBD-loaded liposome platform technology... Read more